| Year |
Citation |
Score |
| 2023 |
Farias Amorim C, Lovins VM, Singh TP, Novais FO, Harris JC, Lago AS, Carvalho LP, Carvalho EM, Beiting DP, Scott P, Grice EA. Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity. Science Translational Medicine. 15: eadh1469. PMID 37851822 DOI: 10.1126/scitranslmed.adh1469 |
0.338 |
|
| 2023 |
Peixoto FC, Zanette DL, Cardoso TM, Nascimento MT, Sanches RCO, Aoki M, Scott P, Oliveira SC, Carvalho EM, Carvalho LP. exosomes activate human macrophages to produce proinflammatory mediators. Frontiers in Immunology. 14: 1256425. PMID 37841240 DOI: 10.3389/fimmu.2023.1256425 |
0.336 |
|
| 2023 |
Singh TP, Farias Amorim C, Lovins VM, Bradley CW, Carvalho LP, Carvalho EM, Grice EA, Scott P. Regulatory T cells control Staphylococcus aureus and disease severity of cutaneous leishmaniasis. The Journal of Experimental Medicine. 220. PMID 37812390 DOI: 10.1084/jem.20230558 |
0.352 |
|
| 2023 |
Sacramento LA, Farias Amorim C, Campos TM, Saldanha M, Arruda S, Carvalho LP, Beiting DP, Carvalho EM, Novais FO, Scott P. NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis. Plos Neglected Tropical Diseases. 17: e0011552. PMID 37603573 DOI: 10.1371/journal.pntd.0011552 |
0.359 |
|
| 2023 |
Farias Amorim C, Lovins VM, Singh TP, Novais FO, Harris JC, Lago AS, Carvalho LP, Carvalho EM, Beiting DP, Scott P, Grice EA. The skin microbiome enhances disease through IL-1b and delays healing in cutaneous leishmaniasis patients. Medrxiv : the Preprint Server For Health Sciences. PMID 36798406 DOI: 10.1101/2023.02.02.23285247 |
0.319 |
|
| 2022 |
Weinkopff T, Roys H, Bowlin A, Scott P. Erratum for Weinkopff et al., " Infection Induces Macrophage Vascular Endothelial Growth Factor A Production in an ARNT/HIF-Dependent Manner". Infection and Immunity. 90: e0001922. PMID 35377173 DOI: 10.1128/iai.00019-22 |
0.707 |
|
| 2021 |
Farias Amorim C, O Novais F, Nguyen BT, Nascimento MT, Lago J, Lago AS, Carvalho LP, Beiting DP, Scott P. Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature. Plos Neglected Tropical Diseases. 15: e0009321. PMID 33793565 DOI: 10.1371/journal.pntd.0009321 |
0.311 |
|
| 2020 |
Scott P. Long-Lived Skin-Resident Memory T Cells Contribute to Concomitant Immunity in Cutaneous Leishmaniasis. Cold Spring Harbor Perspectives in Biology. PMID 32839202 DOI: 10.1101/Cshperspect.A038059 |
0.408 |
|
| 2020 |
Saldanha MG, Pagliari C, Queiroz A, Machado PRL, Carvalho L, Scott P, Carvalho EM, Arruda S. Tissue Damage in Human Cutaneous Leishmaniasis: Correlations Between Inflammatory Cells and Molecule Expression. Frontiers in Cellular and Infection Microbiology. 10: 355. PMID 32766167 DOI: 10.3389/Fcimb.2020.00355 |
0.408 |
|
| 2020 |
Novais FO, Nguyen BT, Scott P. Granzyme B inhibition by tofacitinib blocks pathology induced by CD8 T cells in cutaneous leishmaniasis. The Journal of Investigative Dermatology. PMID 32738245 DOI: 10.1016/J.Jid.2020.07.011 |
0.437 |
|
| 2019 |
Campos TM, Novais FO, Saldanha M, Costa R, Lordelo M, Celestino D, Sampaio C, Tavares N, Arruda S, Machado P, Brodskyn C, Scott P, Carvalho EM, Carvalho LP. Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis. The Journal of Infectious Diseases. PMID 31748808 DOI: 10.1093/Infdis/Jiz538 |
0.434 |
|
| 2019 |
Weinkopff T, Roys H, Bowlin A, Scott P. infection induces macrophage VEGF-A production in a ARNT/HIF-dependent manner. Infection and Immunity. PMID 31451620 DOI: 10.1128/Iai.00088-19 |
0.746 |
|
| 2019 |
Carvalho AM, Novais FO, Paixão CS, de Oliveira CI, Lima Machado PR, Carvalho LP, Scott P, Carvalho EM. Glyburide, a NLRP3 inhibitor, decreases inflammatory response and is a candidate to reduce pathology in Leishmania braziliensis infection. The Journal of Investigative Dermatology. PMID 31252034 DOI: 10.1016/J.Jid.2019.05.025 |
0.364 |
|
| 2019 |
Louis L, Clark M, Wise MC, Glennie N, Wong A, Broderick K, Uzonna J, Weiner DB, Scott P. Intradermal synDNA vaccination generates Leishmania specific T cells in the skin and protection against . Infection and Immunity. PMID 31182618 DOI: 10.1128/Iai.00227-19 |
0.367 |
|
| 2019 |
Polari LP, Carneiro PP, Macedo M, Machado PRL, Scott P, Carvalho EM, Bacellar O. Infection Enhances Toll-Like Receptors 2 and 4 Expression and Triggers TNF-α and IL-10 Production in Human Cutaneous Leishmaniasis. Frontiers in Cellular and Infection Microbiology. 9: 120. PMID 31119102 DOI: 10.3389/Fcimb.2019.00120 |
0.413 |
|
| 2018 |
Jašarević E, Howard CD, Morrison K, Misic A, Weinkopff T, Scott P, Hunter C, Beiting D, Bale TL. The maternal vaginal microbiome partially mediates the effects of prenatal stress on offspring gut and hypothalamus. Nature Neuroscience. PMID 29988069 DOI: 10.1038/S41593-018-0182-5 |
0.678 |
|
| 2018 |
Novais FO, Wong AC, Villareal DO, Beiting DP, Scott P. CD8+ T Cells Lack Local Signals To Produce IFN-γ in the Skin during Leishmania Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 29367210 DOI: 10.4049/Jimmunol.1701597 |
0.472 |
|
| 2017 |
Santos D, Campos TM, Saldanha M, Oliveira SC, Nascimento M, Zamboni DS, Machado PR, Arruda S, Scott P, Carvalho EM, Carvalho LP. IL-1β production by intermediate monocytes is associated with immunopathology in cutaneous leishmaniasis. The Journal of Investigative Dermatology. PMID 29246797 DOI: 10.1016/J.Jid.2017.11.029 |
0.399 |
|
| 2017 |
Costa RS, Carvalho LP, Campos TM, Magalhães AS, Passos ST, Schriefer A, Silva JA, Lago E, Paixão CS, Machado P, Scott P, Carvalho EM. Early Cutaneous Leishmaniasis Patients Infected with Leishmania braziliensis Express Increased Inflammatory Responses Following Antimony Therapy. The Journal of Infectious Diseases. PMID 29216363 DOI: 10.1093/Infdis/Jix627 |
0.308 |
|
| 2017 |
Gimblet C, Meisel JS, Loesche MA, Cole SD, Horwinski J, Novais FO, Misic AM, Bradley CW, Beiting DP, Rankin SC, Carvalho LP, Carvalho EM, Scott P, Grice EA. Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation. Cell Host & Microbe. PMID 28669672 DOI: 10.1016/J.Chom.2017.06.006 |
0.34 |
|
| 2017 |
Glennie ND, Volk SW, Scott P. Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes. Plos Pathogens. 13: e1006349. PMID 28419151 DOI: 10.1371/Journal.Ppat.1006349 |
0.406 |
|
| 2017 |
Novais FO, Carvalho AM, Clark ML, Carvalho LP, Beiting DP, Brodsky IE, Carvalho EM, Scott P. CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production. Plos Pathogens. 13: e1006196. PMID 28192528 DOI: 10.1371/Journal.Ppat.1006196 |
0.447 |
|
| 2017 |
Saldanha MG, Queiroz A, Machado PR, de Carvalho LP, Scott P, de Carvalho Filho EM, Arruda S. Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis. The American Journal of Tropical Medicine and Hygiene. PMID 28115669 DOI: 10.4269/Ajtmh.16-0539 |
0.357 |
|
| 2016 |
Christensen SM, Dillon LA, Carvalho LP, Passos S, Novais FO, Hughitt VK, Beiting DP, Carvalho EM, Scott P, El-Sayed NM, Mosser DM. Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion. Plos Neglected Tropical Diseases. 10: e0004992. PMID 27631090 DOI: 10.1371/Journal.Pntd.0004992 |
0.364 |
|
| 2016 |
Glennie ND, Scott P. Memory T cells in cutaneous leishmaniasis. Cellular Immunology. PMID 27493096 DOI: 10.1016/J.Cellimm.2016.07.010 |
0.392 |
|
| 2016 |
Weinkopff T, Konradt C, Christian DA, Discher DE, Hunter CA, Scott P. Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease. Journal of Immunology (Baltimore, Md. : 1950). PMID 27474074 DOI: 10.4049/Jimmunol.1600717 |
0.735 |
|
| 2016 |
Scott P, Novais FO. Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nature Reviews. Immunology. PMID 27424773 DOI: 10.1038/Nri.2016.72 |
0.451 |
|
| 2015 |
Crosby EJ, Clark M, Novais FO, Wherry EJ, Scott P. Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbate Disease in Mice Coinfected with Leishmania major. Journal of Immunology (Baltimore, Md. : 1950). PMID 26290604 DOI: 10.4049/Jimmunol.1500855 |
0.49 |
|
| 2015 |
Gimblet C, Loesche MA, Carvalho L, Carvalho EM, Grice EA, Artis D, Scott P. IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis. Plos One. 10: e0134698. PMID 26285207 DOI: 10.1371/Journal.Pone.0134698 |
0.446 |
|
| 2015 |
Glennie ND, Yeramilli VA, Beiting DP, Volk SW, Weaver CT, Scott P. Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection. The Journal of Experimental Medicine. 212: 1405-14. PMID 26216123 DOI: 10.1084/Jem.20142101 |
0.433 |
|
| 2015 |
Novais FO, Scott P. CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly. Seminars in Immunopathology. 37: 251-9. PMID 25800274 DOI: 10.1007/S00281-015-0475-7 |
0.412 |
|
| 2015 |
Cardoso TM, Machado Ã, Costa DL, Carvalho LP, Queiroz A, Machado P, Scott P, Carvalho EM, Bacellar O. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection. Infection and Immunity. 83: 898-906. PMID 25534940 DOI: 10.1128/Iai.02404-14 |
0.44 |
|
| 2015 |
Passos S, Carvalho LP, Costa RS, Campos TM, Novais FO, Magalhães A, Machado PR, Beiting D, Mosser D, Carvalho EM, Scott P. Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections. The Journal of Infectious Diseases. 211: 274-82. PMID 25139016 DOI: 10.1093/Infdis/Jiu439 |
0.398 |
|
| 2015 |
Novais FO, Carvalho LP, Passos S, Roos DS, Carvalho EM, Scott P, Beiting DP. Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology. The Journal of Investigative Dermatology. 135: 94-101. PMID 25036052 DOI: 10.1038/Jid.2014.305 |
0.335 |
|
| 2014 |
Crosby EJ, Goldschmidt MH, Wherry EJ, Scott P. Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection. Plos Pathogens. 10: e1003970. PMID 24586170 DOI: 10.1371/Journal.Ppat.1003970 |
0.466 |
|
| 2014 |
Novais FO, Nguyen BT, Beiting DP, Carvalho LP, Glennie ND, Passos S, Carvalho EM, Scott P. Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species. The Journal of Infectious Diseases. 209: 1288-96. PMID 24403561 DOI: 10.1093/Infdis/Jiu013 |
0.354 |
|
| 2013 |
Carvalho AM, Magalhães A, Carvalho LP, Bacellar O, Scott P, Carvalho EM. Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis. Bmc Infectious Diseases. 13: 529. PMID 24206576 DOI: 10.1186/1471-2334-13-529 |
0.437 |
|
| 2013 |
Novais FO, Carvalho LP, Graff JW, Beiting DP, Ruthel G, Roos DS, Betts MR, Goldschmidt MH, Wilson ME, de Oliveira CI, Scott P. Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. Plos Pathogens. 9: e1003504. PMID 23874205 DOI: 10.1371/Journal.Ppat.1003504 |
0.476 |
|
| 2013 |
Gonzalez-Lombana C, Gimblet C, Bacellar O, Oliveira WW, Passos S, Carvalho LP, Goldschmidt M, Carvalho EM, Scott P. IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. Plos Pathogens. 9: e1003243. PMID 23555256 DOI: 10.1371/Journal.Ppat.1003243 |
0.425 |
|
| 2013 |
Schamber-Reis BL, Petritus PM, Caetano BC, Martinez ER, Okuda K, Golenbock D, Scott P, Gazzinelli RT. UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major. The Journal of Biological Chemistry. 288: 7127-36. PMID 23325805 DOI: 10.1074/Jbc.M112.407684 |
0.385 |
|
| 2013 |
Petritus PM, Manzoni-de-Almeida D, Gimblet C, Lombana CG, Scott P. Fewer CD11b hi Ly6C + cells in the ear following L. mexicana infection compared to L. major . Plos Neglected Tropical Diseases. DOI: 10.1371/Journal.Pntd.0001858.G001 |
0.342 |
|
| 2013 |
Gimblet C, Artis D, Scott P. 94 Cytokine. 63: 265. DOI: 10.1016/J.Cyto.2013.06.097 |
0.468 |
|
| 2012 |
Petritus PM, Manzoni-de-Almeida D, Gimblet C, Gonzalez Lombana C, Scott P. Leishmania mexicana induces limited recruitment and activation of monocytes and monocyte-derived dendritic cells early during infection. Plos Neglected Tropical Diseases. 6: e1858. PMID 23094119 DOI: 10.1371/Journal.Pntd.0001858 |
0.465 |
|
| 2012 |
Passos S, Menezes T, Costa R, Mosser D, Scott P, Carvalho E, Carvalho L. P030 Subsets of circulating monocytes differently contribute to immunopathology in cutaneous leishmaniasis Cytokine. 59: 527-528. DOI: 10.1016/J.Cyto.2012.06.113 |
0.387 |
|
| 2011 |
Scott P. Leishmania - A parasitized parasite New England Journal of Medicine. 364: 1773-1774. PMID 21542750 DOI: 10.1056/Nejmcibr1101694 |
0.39 |
|
| 2010 |
Colpitts S, Scott P. Memory T-cell subsets in parasitic infections. Advances in Experimental Medicine and Biology. 684: 145-54. PMID 20795546 DOI: 10.1007/978-1-4419-6451-9_11 |
0.395 |
|
| 2010 |
Colpitts SL, Scott P. The early generation of a heterogeneous CD4+ T cell response to Leishmania major. Journal of Immunology (Baltimore, Md. : 1950). 185: 2416-23. PMID 20624946 DOI: 10.4049/jimmunol.1000483 |
0.333 |
|
| 2009 |
Liu J, Carvalho LP, Bhattacharya S, Carbone CJ, Kumar KG, Leu NA, Yau PM, Donald RG, Weiss MJ, Baker DP, McLaughlin KJ, Scott P, Fuchs SY. Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling. Molecular and Cellular Biology. 29: 6401-12. PMID 19805514 DOI: 10.1128/Mcb.00478-09 |
0.332 |
|
| 2009 |
Scott P. Finding Leishmania: a deadly game of hide-and-seek. Cell Host & Microbe. 6: 3-4. PMID 19616760 DOI: 10.1016/J.Chom.2009.07.002 |
0.389 |
|
| 2009 |
Liu D, Kebaier C, Pakpour N, Capul AA, Beverley SM, Scott P, Uzonna JE. Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions. Infection and Immunity. 77: 3272-83. PMID 19487470 DOI: 10.1128/Iai.01447-08 |
0.514 |
|
| 2009 |
Bacellar O, Faria D, Nascimento M, Cardoso TM, Gollob KJ, Dutra WO, Scott P, Carvalho EM. Interleukin 17 production among patients with American cutaneous leishmaniasis. The Journal of Infectious Diseases. 200: 75-8. PMID 19476435 DOI: 10.1086/599380 |
0.402 |
|
| 2009 |
Colpitts SL, Dalton NM, Scott P. IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection. Journal of Immunology (Baltimore, Md. : 1950). 182: 5702-11. PMID 19380817 DOI: 10.4049/jimmunol.0803450 |
0.383 |
|
| 2008 |
Carvalho LP, Pearce EJ, Scott P. Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-alpha, whereas bystander dendritic cells are activated to promote T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 181: 6473-80. PMID 18941238 DOI: 10.4049/Jimmunol.181.9.6473 |
0.437 |
|
| 2008 |
Pakpour N, Zaph C, Scott P. The central memory CD4+ T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma. Journal of Immunology (Baltimore, Md. : 1950). 180: 8299-305. PMID 18523296 DOI: 10.4049/Jimmunol.180.12.8299 |
0.463 |
|
| 2007 |
Hsu AC, Scott P. Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation Journal of Immunology. 179: 8200-8207. PMID 18056363 DOI: 10.4049/Jimmunol.179.12.8200 |
0.444 |
|
| 2007 |
Johnson LM, Scott P. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major. Journal of Immunology (Baltimore, Md. : 1950). 178: 7259-66. PMID 17513775 DOI: 10.4049/Jimmunol.178.11.7259 |
0.444 |
|
| 2007 |
Perrigoue JG, Li J, Zaph C, Goldschmidt M, Scott P, de Sauvage FJ, Pearce EJ, Ghilardi N, Artis D. IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. The Journal of Experimental Medicine. 204: 481-7. PMID 17353366 DOI: 10.1084/Jem.20061791 |
0.428 |
|
| 2006 |
Gray PM, Reiner SL, Smith DF, Kaye PM, Scott P. Antigen-experienced T cells limit the priming of naive T cells during infection with Leishmania major. Journal of Immunology (Baltimore, Md. : 1950). 177: 925-33. PMID 16818747 DOI: 10.4049/Jimmunol.177.2.925 |
0.424 |
|
| 2006 |
Zaph C, Rook KA, Goldschmidt M, Mohrs M, Scott P, Artis D. Persistence and function of central and effector memory CD4+ T cells following infection with a gastrointestinal helminth. Journal of Immunology (Baltimore, Md. : 1950). 177: 511-8. PMID 16785548 DOI: 10.4049/Jimmunol.177.1.511 |
0.412 |
|
| 2006 |
Prickett S, Gray PM, Colpitts SL, Scott P, Kaye PM, Smith DF. In vivo recognition of ovalbumin expressed by transgenic Leishmania is determined by its subcellular localization. Journal of Immunology (Baltimore, Md. : 1950). 176: 4826-33. PMID 16585577 DOI: 10.4049/Jimmunol.176.8.4826 |
0.387 |
|
| 2006 |
Kébaïer C, Uzonna JE, Beverley SM, Scott P. Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice. Infection and Immunity. 74: 777-80. PMID 16369039 DOI: 10.1128/Iai.74.1.777-780.2006 |
0.388 |
|
| 2006 |
Sweeney RW, Uzonna J, Whitlock RH, Habecker PL, Chilton P, Scott P. Tissue predilection sites and effect of dose on Mycobacterium avium subs. paratuberculosis organism recovery in a short-term bovine experimental oral infection model Research in Veterinary Science. 80: 253-259. PMID 16165171 DOI: 10.1016/J.Rvsc.2005.07.007 |
0.319 |
|
| 2005 |
Scott P. Immunologic memory in cutaneous leishmaniasis. Cellular Microbiology. 7: 1707-1713. PMID 16309457 DOI: 10.1111/J.1462-5822.2005.00626.X |
0.423 |
|
| 2005 |
Hutchins AS, Artis D, Hendrich BD, Bird AP, Scott P, Reiner SL. Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunity. Journal of Immunology (Baltimore, Md. : 1950). 175: 5606-10. PMID 16237047 DOI: 10.4049/Jimmunol.175.9.5606 |
0.443 |
|
| 2005 |
Oliveira MR, Tafuri WL, Afonso LC, Oliveira MA, Nicoli JR, Vieira EC, Scott P, Melo MN, Vieira LQ. Germ-free mice produce high levels of interferon-gamma in response to infection with Leishmania major but fail to heal lesions. Parasitology. 131: 477-88. PMID 16174412 DOI: 10.1017/S0031182005008073 |
0.484 |
|
| 2005 |
Artis D, Kane CM, Fiore J, Zaph C, Shapira S, Joyce K, Macdonald A, Hunter C, Scott P, Pearce EJ. Dendritic cell-intrinsic expression of NF-kappa B1 is required to promote optimal Th2 cell differentiation. Journal of Immunology (Baltimore, Md. : 1950). 174: 7154-9. PMID 15905559 DOI: 10.4049/Jimmunol.174.11.7154 |
0.43 |
|
| 2005 |
Buxbaum LU, Scott P. Interleukin 10- and Fcγ Receptor-Deficient Mice Resolve Leishmania mexicana Lesions Infection and Immunity. 73: 2101-2108. PMID 15784551 DOI: 10.1128/Iai.73.4.2101-2108.2005 |
0.454 |
|
| 2005 |
Hunter CA, Villarino A, Artis D, Scott P. The role of IL-27 in the development of T-cell responses during parasitic infections. Immunological Reviews. 202: 106-14. PMID 15546389 DOI: 10.1111/J.0105-2896.2004.00213.X |
0.459 |
|
| 2005 |
Scott P, Artis D, Uzonna J, Zaph C. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development. Immunological Reviews. 201: 318-38. PMID 15361250 DOI: 10.1111/J.0105-2896.2004.00198.X |
0.447 |
|
| 2004 |
Artis D, Villarino A, Silverman M, He W, Thornton EM, Mu S, Summer S, Covey TM, Huang E, Yoshida H, Koretzky G, Goldschmidt M, Wu GD, de Sauvage F, Miller HR, ... ... Scott P, et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. Journal of Immunology (Baltimore, Md. : 1950). 173: 5626-34. PMID 15494513 DOI: 10.4049/Jimmunol.173.9.5626 |
0.459 |
|
| 2004 |
Zaph C, Uzonna J, Beverley SM, Scott P. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nature Medicine. 10: 1104-10. PMID 15448686 DOI: 10.1038/Nm1108 |
0.306 |
|
| 2004 |
Robinson TM, Nelson R, Artis D, Scott P, Boyer JD. Experimental Leishmania major infection suppresses HIV-1 DNA vaccine induced cellular immune response. Cells, Tissues, Organs. 177: 185-8. PMID 15388992 DOI: 10.1159/000079992 |
0.401 |
|
| 2004 |
Dalton JE, Howell G, Pearson J, Scott P, Carding SR. Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 3660-7. PMID 15356111 DOI: 10.4049/Jimmunol.173.6.3660 |
0.409 |
|
| 2004 |
Artis D, Wang ML, Keilbaugh SA, He W, Brenes M, Swain GP, Knight PA, Donaldson DD, Lazar MA, Miller HR, Schad GA, Scott P, Wu GD. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proceedings of the National Academy of Sciences of the United States of America. 101: 13596-600. PMID 15340149 DOI: 10.1073/Pnas.0404034101 |
0.518 |
|
| 2004 |
Uzonna JE, Joyce KL, Scott P. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon γ-producing CD8+ T cells Journal of Experimental Medicine. 199: 1559-1566. PMID 15184505 DOI: 10.1084/Jem.20040172 |
0.452 |
|
| 2004 |
Artis D, Johnson LM, Joyce K, Saris C, Villarino A, Hunter CA, Scott P. Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection. Journal of Immunology (Baltimore, Md. : 1950). 172: 4672-5. PMID 15067040 DOI: 10.4049/Jimmunol.172.8.4672 |
0.444 |
|
| 2004 |
Uzonna JE, Späth GF, Beverley SM, Scott P. Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response. Journal of Immunology (Baltimore, Md. : 1950). 172: 3793-7. PMID 15004184 DOI: 10.4049/Jimmunol.172.6.3793 |
0.486 |
|
| 2004 |
Lemos MP, Esquivel F, Scott P, Laufer TM. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. The Journal of Experimental Medicine. 199: 725-30. PMID 14993255 DOI: 10.1084/Jem.20030795 |
0.451 |
|
| 2004 |
Speirs K, Lieberman L, Caamano J, Hunter CA, Scott P. Cutting Edge: NF-κB2 Is a Negative Regulator of Dendritic Cell Function Journal of Immunology. 172: 752-756. PMID 14707043 DOI: 10.4049/Jimmunol.172.2.752 |
0.337 |
|
| 2003 |
Dalton JE, Pearson J, Scott P, Carding SR. The interaction of gamma delta T cells with activated macrophages is a property of the V gamma 1 subset. Journal of Immunology (Baltimore, Md. : 1950). 171: 6488-94. PMID 14662848 DOI: 10.4049/Jimmunol.171.12.6488 |
0.399 |
|
| 2003 |
Zaph C, Scott P. Th1 Cell-Mediated Resistance to Cutaneous Infection with Leishmania major Is Independent of P- and E-Selectins Journal of Immunology. 171: 4726-4732. PMID 14568948 DOI: 10.4049/Jimmunol.171.9.4726 |
0.472 |
|
| 2003 |
Buxbaum LU, Denise H, Coombs GH, Alexander J, Mottram JC, Scott P. Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. Journal of Immunology (Baltimore, Md. : 1950). 171: 3711-7. PMID 14500670 DOI: 10.4049/Jimmunol.171.7.3711 |
0.456 |
|
| 2003 |
Kobayashi T, Walsh PT, Walsh MC, Speirs KM, Chiffoleau E, King CG, Hancock WW, Caamano JH, Hunter CA, Scott P, Turka LA, Choi Y. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity. 19: 353-63. PMID 14499111 DOI: 10.1016/S1074-7613(03)00230-9 |
0.399 |
|
| 2003 |
Scott P. Development and regulation of cell-mediated immunity in experimental leishmaniasis. Immunologic Research. 27: 489-498. PMID 12857992 DOI: 10.1385/Ir:27:2-3:489 |
0.491 |
|
| 2003 |
Zaph C, Scott P. Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major. Infection and Immunity. 71: 1587-1589. PMID 12595483 DOI: 10.1128/Iai.71.3.1587-1589.2003 |
0.42 |
|
| 2003 |
Artis D, Speirs K, Joyce K, Goldschmidt M, Caamaño J, Hunter CA, Scott P. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major. Journal of Immunology (Baltimore, Md. : 1950). 170: 1995-2003. PMID 12574369 DOI: 10.4049/Jimmunol.170.4.1995 |
0.517 |
|
| 2003 |
Pollock KG, McNeil KS, Mottram JC, Lyons RE, Brewer JM, Scott P, Coombs GH, Alexander J. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. Journal of Immunology (Baltimore, Md. : 1950). 170: 1746-53. PMID 12574338 DOI: 10.4049/Jimmunol.170.4.1746 |
0.467 |
|
| 2002 |
Buxbaum LU, Uzonna JE, Goldschmidt MH, Scott P. Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent European Journal of Immunology. 32: 3206-3215. PMID 12555666 DOI: 10.1002/1521-4141(200211)32:11<3206::Aid-Immu3206>3.0.Co;2-J |
0.47 |
|
| 2002 |
Krolewiecki A, Leon S, Scott P, Abraham D. Activity of azithromycin against Leishmania major in vitro and in vivo. American Journal of Tropical Medicine and Hygiene. 67: 273-277. PMID 12408666 DOI: 10.4269/Ajtmh.2002.67.273 |
0.441 |
|
| 2002 |
Artis D, Shapira S, Mason N, Speirs KM, Goldschmidt M, Caamaño J, Liou HC, Hunter CA, Scott P. Differential requirement for NF-kappa B family members in control of helminth infection and intestinal inflammation. Journal of Immunology (Baltimore, Md. : 1950). 169: 4481-7. PMID 12370384 DOI: 10.4049/Jimmunol.169.8.4481 |
0.444 |
|
| 2002 |
Li J, Padigel UM, Scott P, Farrell JP. Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infections. Infection and Immunity. 70: 5715-20. PMID 12228301 DOI: 10.1128/Iai.70.10.5715-5720.2002 |
0.469 |
|
| 2002 |
La Flamme AC, Scott P, Pearce EJ. Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophages. Parasite Immunology. 24: 339-45. PMID 12164819 DOI: 10.1046/J.1365-3024.2002.00473.X |
0.508 |
|
| 2002 |
Scott P, Hunter CA. Dendritic cells and immunity to leishmaniasis and toxoplasmosis Current Opinion in Immunology. 14: 466-470. PMID 12088681 DOI: 10.1016/S0952-7915(02)00353-9 |
0.393 |
|
| 2002 |
Park AY, Hondowicz B, Kopf M, Scott P. The role of IL-12 in maintaining resistance to Leishmania major. Journal of Immunology (Baltimore, Md. : 1950). 168: 5771-7. PMID 12023378 DOI: 10.4049/Jimmunol.168.11.5771 |
0.455 |
|
| 2002 |
Speirs K, Caamano J, Goldschmidt MH, Hunter CA, Scott P. NF-κB2 Is Required for Optimal CD40-Induced IL-12 Production but Dispensable for Th1 Cell Differentiation Journal of Immunology. 168: 4406-4413. PMID 11970983 DOI: 10.4049/Jimmunol.168.9.4406 |
0.424 |
|
| 2002 |
Jones DE, Ackermann MR, Wille U, Hunter CA, Scott P. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infection and Immunity. 70: 2151-8. PMID 11895981 DOI: 10.1128/Iai.70.4.2151-2158.2002 |
0.502 |
|
| 2002 |
Hondowicz B, Scott P. Influence of parasite load on the ability of type 1 T cells to control Leishmania major infection. Infection and Immunity. 70: 498-503. PMID 11796575 DOI: 10.1128/Iai.70.2.498-503.2002 |
0.471 |
|
| 2001 |
Riley MP, Shih FF, Jordan MS, Petrone AL, Cerasoli DM, Scott P, Caton AJ. CD4+ T cells that evade deletion by a self peptide display Th1-biased differentiation. European Journal of Immunology. 31: 311-9. PMID 11265648 DOI: 10.1002/1521-4141(200101)31:1<311::Aid-Immu311>3.0.Co;2-G |
0.377 |
|
| 2001 |
Elloso MM, Scott P. Differential requirement of CD28 for IL‐12 receptor expression and function in CD4+ and CD8+ T cells European Journal of Immunology. 31: 384-395. PMID 11180102 DOI: 10.1002/1521-4141(200102)31:2<384::Aid-Immu384>3.0.Co;2-9 |
0.381 |
|
| 2001 |
Constantinescu CS, Hilliard B, Ventura E, Wysocka M, Showe L, Lavi E, Fujioka T, Scott P, Trinchieri G, Rostami A. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively. Clinical Immunology (Orlando, Fla.). 98: 23-30. PMID 11141323 DOI: 10.1006/Clim.2000.4944 |
0.4 |
|
| 2001 |
Gicheru MM, Olobo JO, Anjili CO, Orago AS, Modabber F, Scott P. Vervet Monkeys Vaccinated with Killed Leishmania major Parasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against Challenge Infection Infection and Immunity. 69: 245-251. PMID 11119512 DOI: 10.1128/Iai.69.1.245-251.2001 |
0.475 |
|
| 2000 |
Hondowicz BD, Park AY, Elloso MM, Scott P. Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice. European Journal of Immunology. 30: 2007-14. PMID 10940890 DOI: 10.1002/1521-4141(200007)30:7<2007::Aid-Immu2007>3.0.Co;2-W |
0.446 |
|
| 2000 |
Park AY, Hondowicz BD, Scott P. IL-12 is required to maintain a Th1 response during Leishmania major infection. Journal of Immunology (Baltimore, Md. : 1950). 165: 896-902. PMID 10878364 DOI: 10.4049/Jimmunol.165.2.896 |
0.476 |
|
| 2000 |
Jones DE, Buxbaum LU, Scott P. IL-4-Independent Inhibition of IL-12 Responsiveness During Leishmania amazonensis Infection Journal of Immunology. 165: 364-372. PMID 10861073 DOI: 10.4049/Jimmunol.165.1.364 |
0.453 |
|
| 2000 |
Lee JY, Atochina O, King B, Taylor L, Elloso M, Scott P, Rossman MD. Beryllium, an adjuvant that promotes gamma interferon production. Infection and Immunity. 68: 4032-9. PMID 10858219 DOI: 10.1128/Iai.68.7.4032-4039.2000 |
0.445 |
|
| 2000 |
Nashleanas M, Scott P. Activated T Cells Induce Macrophages To Produce NO and Control Leishmania major in the Absence of Tumor Necrosis Factor Receptor p55 Infection and Immunity. 68: 1428-1434. PMID 10678956 DOI: 10.1128/Iai.68.3.1428-1434.2000 |
0.421 |
|
| 1999 |
Hondowicz B, Scott P. Influence of host and parasite factors on the innate immune response and Th2 stability following infection with Leishmania major. Microbes and Infection. 1: 65-71. PMID 10847768 DOI: 10.1016/S1286-4579(99)80016-1 |
0.407 |
|
| 1999 |
Fernandez-Botran R, Chilton PM, Hondowicz BD, Vetvickova J, Yan J, Jones W, Scott P. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4. Journal of Leukocyte Biology. 66: 481-488. PMID 10496319 DOI: 10.1002/Jlb.66.3.481 |
0.422 |
|
| 1998 |
Constantinescu CS, Hondowicz BD, Elloso MM, Wysocka M, Trinchieri G, Scott P. The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis. European Journal of Immunology. 28: 2227-2233. PMID 9692892 DOI: 10.1002/(Sici)1521-4141(199807)28:07<2227::Aid-Immu2227>3.0.Co;2-N |
0.504 |
|
| 1998 |
Jones D, Elloso MM, Showe L, Williams D, Trinchieri G, Scott P. Differential Regulation of the Interleukin-12 Receptor during the Innate Immune Response to Leishmania major Infection and Immunity. 66: 3818-3824. PMID 9673267 DOI: 10.1128/Iai.66.8.3818-3824.1998 |
0.447 |
|
| 1998 |
Scott P, Farrell JP. Experimental cutaneous leishmaniasis: induction and regulation of T cells following infection of mice with Leishmania major. Chemical Immunology. 70: 60-80. PMID 9509670 DOI: 10.1159/000058698 |
0.448 |
|
| 1998 |
Scott P. Differentiation, regulation, and death of T helper cell subsets during infection with Leishmania major Immunologic Research. 17: 229-238. PMID 9479584 DOI: 10.1007/Bf02786447 |
0.522 |
|
| 1997 |
Scott P, Trinchieri G. IL-12 as an adjuvant for cell-mediated immunity. Seminars in Immunology. 9: 285-291. PMID 9327523 DOI: 10.1006/Smim.1997.0084 |
0.397 |
|
| 1997 |
Rotman HL, Schnyder-Candrian S, Scott P, Nolan TJ, Schad GA, Abraham D. IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunology. 19: 29-39. PMID 9121838 DOI: 10.1046/J.1365-3024.1997.D01-142.X |
0.466 |
|
| 1996 |
Scott P, Hondowicz B, Eaton A, Scharton-Kersten T. The role of IL-12 in regulation of T helper cell subsets in vivo. Lessons from experimental cutaneous leishmaniasis. Annals of the New York Academy of Sciences. 795: 250-6. PMID 8958936 DOI: 10.1111/J.1749-6632.1996.Tb52674.X |
0.406 |
|
| 1996 |
Li J, Scott P, Farrell JP. In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis. Infection and Immunity. 64: 5248-54. PMID 8945573 DOI: 10.1128/Iai.64.12.5248-5254.1996 |
0.465 |
|
| 1996 |
Scott P, Eaton A, Gause WC, di Zhou X, Hondowicz B. Early IL-4 production does not predict susceptibility to Leishmania major. Experimental Parasitology. 84: 178-87. PMID 8932767 DOI: 10.1006/Expr.1996.0103 |
0.43 |
|
| 1996 |
Scott P. Th cell development and regulation in experimental cutaneous leishmaniasis. Chemical Immunology. 63: 98-114. DOI: 10.1159/000319481 |
0.334 |
|
| 1995 |
Scott P, Trinchieri G. The role of natural killer cells in host—parasite interactions Current Opinion in Immunology. 7: 34-40. PMID 7772279 DOI: 10.1016/0952-7915(95)80026-3 |
0.369 |
|
| 1995 |
Nabors GS, Afonso LC, Farrell JP, Scott P. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proceedings of the National Academy of Sciences of the United States of America. 92: 3142-6. PMID 7724530 DOI: 10.1073/Pnas.92.8.3142 |
0.476 |
|
| 1995 |
Scharton-Kersten T, Scott P. The role of the innate immune response in Th1 cell development following Leishmania major infection. Journal of Leukocyte Biology. 57: 515-522. PMID 7722408 DOI: 10.1002/Jlb.57.4.515 |
0.498 |
|
| 1995 |
Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P, Trinchieri G. Interleukin-12 Is Required For Interferon-Gamma Production And Lethality In Lipopolysaccharide-Induced Shock In Mice European Journal of Immunology. 25: 672-676. PMID 7705395 DOI: 10.1002/Eji.1830250307 |
0.378 |
|
| 1994 |
Scott P, Scharton T. Interaction between the Innate and the Acquired Immune System following Infection of Different Mouse Strains with Leishmania majora Annals of the New York Academy of Sciences. 730: 84-92. PMID 8080217 DOI: 10.1111/J.1749-6632.1994.Tb44241.X |
0.362 |
|
| 1994 |
Trinchieri G, Scott P. The role of interleukin 12 in the immune response, disease and therapy Immunology Today. 15: 460-463. PMID 7945769 DOI: 10.1016/0167-5699(94)90189-9 |
0.444 |
|
| 1994 |
Vieira LQ, Hondowicz BD, Afonso LCC, Wysocka M, Trinchieri G, Scott P. Infection with Leishmania major induces interleukin-12 production in vivo. Immunology Letters. 40: 157-161. PMID 7916331 DOI: 10.1016/0165-2478(94)90187-2 |
0.486 |
|
| 1994 |
Afonso LCC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major Science. 263: 235-237. PMID 7904381 DOI: 10.1126/Science.7904381 |
0.415 |
|
| 1993 |
Afonso LCC, Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infection and Immunity. 61: 2952-2959. PMID 8514400 DOI: 10.1128/Iai.61.7.2952-2959.1993 |
0.509 |
|
| 1993 |
Reiner SL, Wang ZE, Hatam F, Scott P, Locksley RM. TH1 and TH2 cell antigen receptors in experimental leishmaniasis Science. 259: 1457-1463. PMID 8451641 DOI: 10.1126/Science.8451641 |
0.454 |
|
| 1993 |
Scott P. Selective differentiation of CD4+ T helper cell subsets Current Opinion in Immunology. 5: 391-397. PMID 8102235 DOI: 10.1016/0952-7915(93)90058-Z |
0.38 |
|
| 1993 |
Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. Journal of Experimental Medicine. 178: 567-577. PMID 8101861 DOI: 10.1084/Jem.178.2.567 |
0.478 |
|
| 1993 |
Scott P. IL-12: Initiation cytokine for cell-mediated immunity Science. 260: 496-497. PMID 8097337 DOI: 10.1126/Science.8097337 |
0.408 |
|
| 1991 |
Coffman RL, Varkila K, Scott P, Chatelain R. Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunological Reviews. 123: 189-207. PMID 1684779 DOI: 10.1111/J.1600-065X.1991.Tb00611.X |
0.367 |
|
| 1991 |
Scott P, Kaufmann SHE. The role of T-cell subsets and cytokines in the regulation of infection Immunology Today. 12: 346-348. PMID 1683536 DOI: 10.1016/0167-5699(91)90063-Y |
0.425 |
|
| 1990 |
Scott P, Pearce E, Cheever AW, Coffman RL, Sher A. Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunological Reviews. 112: 161-82. PMID 2575073 DOI: 10.1111/J.1600-065X.1989.Tb00557.X |
0.508 |
|
| 1989 |
Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. CD4+ T cell subsets in experimental cutaneous leishmaniasis. Memorias Do Instituto Oswaldo Cruz. 256-9. PMID 3267029 DOI: 10.1590/S0074-02761988000500006 |
0.334 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Campos TM, Passos ST, Novais FO, Beiting DP, Costa RS, Queiroz A, Mosser D, Scott P, Carvalho EM, Carvalho LP. Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous Leishmaniasis. Plos Neglected Tropical Diseases. 8: e3282. PMID 25393535 DOI: 10.1371/Journal.Pntd.0003282 |
0.295 |
|
| 2021 |
Singh TP, Carvalho AM, Sacramento LA, Grice EA, Scott P. Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis. Plos Pathogens. 17: e1009693. PMID 34699567 DOI: 10.1371/journal.ppat.1009693 |
0.293 |
|
| 1989 |
Miller LH, Scott P. Immunity to protozoa. Current Opinion in Immunology. 2: 368-74. PMID 2699426 DOI: 10.1016/0952-7915(89)90143-X |
0.29 |
|
| 2024 |
Carvalho AM, Costa RS, Lago A, Bacellar O, Beiting DP, Scott P, Carvalho LP, Carvalho EM. In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis. Pathogens (Basel, Switzerland). 13. PMID 38535542 DOI: 10.3390/pathogens13030199 |
0.29 |
|
| 2023 |
Sacramento LA, Amorim CF, Lombana CG, Beiting D, Novais F, Carvalho LP, Carvalho EM, Scott P. CCR5 promotes the migration of CD8 T cells to the leishmanial lesions. Biorxiv : the Preprint Server For Biology. PMID 37873253 DOI: 10.1101/2023.10.10.561700 |
0.283 |
|
| 2019 |
Amorim CF, Novais FO, Nguyen BT, Misic AM, Carvalho LP, Carvalho EM, Beiting DP, Scott P. Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis. Science Translational Medicine. 11. PMID 31748229 DOI: 10.1126/Scitranslmed.Aax4204 |
0.278 |
|
| 2021 |
Fantecelle CH, Covre LP, Garcia de Moura R, de Matos Guedes HL, Amorim CF, Scott P, Mosser D, Falqueto A, Akbar AN, Gomes DCO. Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8 T cell immunosenescence signature linked to immunopathology. Immunology. PMID 34432883 DOI: 10.1111/imm.13410 |
0.258 |
|
| 2008 |
Ng LG, Hsu A, Mandell MA, Roediger B, Hoeller C, Mrass P, Iparraguirre A, Cavanagh LL, Triccas JA, Beverley SM, Scott P, Weninger W. Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. Plos Pathogens. 4: e1000222. PMID 19043558 DOI: 10.1371/Journal.Ppat.1000222 |
0.258 |
|
| 2003 |
Uzonna JE, Chilton P, Whitlock RH, Habecker PL, Scott P, Sweeney RW. Efficacy of commercial and field-strain Mycobacterium paratuberculosis vaccinations with recombinant IL-12 in a bovine experimental infection model. Vaccine. 21: 3101-3109. PMID 12804836 DOI: 10.1016/S0264-410X(03)00261-5 |
0.255 |
|
| 2018 |
Rao SPS, Barrett MP, Dranoff G, Faraday CJ, Gimpelewicz CR, Hailu A, Jones CL, Kelly JM, Lazdins-Helds JK, Mäser P, Mengel J, Mottram JC, Mowbray CE, Sacks DL, Scott P, et al. Drug Discovery for Kinetoplastid Diseases: Future Directions. Acs Infectious Diseases. PMID 30543391 DOI: 10.1021/Acsinfecdis.8B00298 |
0.249 |
|
| 2012 |
Carvalho LP, Petritus PM, Trochtenberg AL, Zaph C, Hill DA, Artis D, Scott P. Lymph node hypertrophy following Leishmania major infection is dependent on TLR9. Journal of Immunology (Baltimore, Md. : 1950). 188: 1394-401. PMID 22205030 DOI: 10.4049/Jimmunol.1101018 |
0.23 |
|
| 2017 |
Christensen SM, Dillon LAL, Carvalho LP, Passos S, Novais FO, Hughitt VK, Beiting DP, Carvalho EM, Scott P, El-Sayed NM, Mosser DM. Correction: Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion. Plos Neglected Tropical Diseases. 11: e0005588. PMID 28467433 DOI: 10.1371/Journal.Pntd.0005588 |
0.229 |
|
| 2007 |
Liu J, Kumar KGS, Carvalho L, Donald RGK, Scott P, Fuchs SY. 89 Regulation of Type I Interferon Receptor Stability and Signaling by Casein Kinase 1-alpha and its Leishmania Orthologue Cytokine. 39: 25-25. DOI: 10.1016/J.Cyto.2007.07.094 |
0.222 |
|
| 2011 |
Kaye P, Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nature Reviews. Microbiology. 9: 604-15. PMID 21747391 DOI: 10.1038/nrmicro2608 |
0.213 |
|
| 2016 |
Davis RE, Sharma S, Conceição J, Carneiro P, Novais F, Scott P, Sundar S, Bacellar O, Carvalho EM, Wilson ME. Phenotypic and functional characteristics of HLA-DR+ neutrophils in Brazilians with cutaneous leishmaniasis. Journal of Leukocyte Biology. PMID 28076241 DOI: 10.1189/Jlb.4A0915-442Rr |
0.186 |
|
| 2023 |
Wertman RS, Go CK, Saller BS, Groß O, Scott P, Brodsky IE. Sequentially activated death complexes regulate pyroptosis and IL-1β release in response to blockade of immune signaling. Biorxiv : the Preprint Server For Biology. PMID 37745613 DOI: 10.1101/2023.09.14.557714 |
0.176 |
|
| 2021 |
Novais FO, Amorim CF, Scott P. Host-Directed Therapies for Cutaneous Leishmaniasis. Frontiers in Immunology. 12: 660183. PMID 33841444 DOI: 10.3389/fimmu.2021.660183 |
0.174 |
|
| 2021 |
Nascimento MT, Franca M, Carvalho AM, Amorim C, Peixoto F, Beiting D, Scott P, Carvalho EM, Carvalho LP. Inhibition of Gamma-secretase activity without interfering in Notch signaling decreases inflammatory response in patients with cutaneous leishmaniasis. Emerging Microbes & Infections. 1-20. PMID 34009107 DOI: 10.1080/22221751.2021.1932608 |
0.162 |
|
| 2011 |
Pulido JN, Neal JR, Mantilla CB, Agarwal S, Lee WY, Scott PD, Hubmayr RD, Zhan WZ, Sieck GC, Farrugia G, Ereth MH. Inhaled carbon monoxide attenuates myocardial inflammatory cytokine expression in a rat model of cardiopulmonary bypass. The Journal of Extra-Corporeal Technology. 43: 137-43. PMID 22164452 |
0.15 |
|
| 2023 |
Pilling OA, Reis-Cunha JL, Grace CA, Berry ASF, Mitchell MW, Yu JA, Malekshahi CR, Krespan E, Go CK, Lombana C, Song YS, Amorim CF, Lago AS, Carvalho LP, Carvalho EM, ... ... Scott P, et al. Selective whole-genome amplification reveals population genetics of Leishmania braziliensis directly from patient skin biopsies. Plos Pathogens. 19: e1011230. PMID 36940219 DOI: 10.1371/journal.ppat.1011230 |
0.14 |
|
| 2020 |
Evans LT, Anglen T, Scott P, Lukasik K, Loncarek J, Holland AJ. ANKRD26 recruits PIDD1 to centriolar distal appendages to activate the PIDDosome following centrosome amplification. The Embo Journal. e105106. PMID 33350495 DOI: 10.15252/embj.2020105106 |
0.132 |
|
| 2014 |
Jin L, Liu Q, Scott P, Zhang D, Shen F, Balian G, Li X. Annulus fibrosus cell characteristics are a potential source of intervertebral disc pathogenesis. Plos One. 9: e96519. PMID 24796761 DOI: 10.1371/journal.pone.0096519 |
0.12 |
|
| 2005 |
Scott P. Immunoparasitology. Immunological Reviews. 201: 5-8. PMID 15361228 DOI: 10.1111/j.0105-2896.2004.00194.x |
0.12 |
|
| 2016 |
Lambrus BG, Daggubati V, Uetake Y, Scott PM, Clutario KM, Sluder G, Holland AJ. A USP28-53BP1-p53-p21 signaling axis arrests growth after centrosome loss or prolonged mitosis. The Journal of Cell Biology. 214: 143-53. PMID 27432896 DOI: 10.1083/Jcb.201604054 |
0.101 |
|
| 2020 |
Park EM, Scott PM, Clutario K, Cassidy KB, Zhan K, Gerber SA, Holland AJ. WBP11 is required for splicing the TUBGCP6 pre-mRNA to promote centriole duplication. The Journal of Cell Biology. 219. PMID 31874114 DOI: 10.1083/Jcb.201904203 |
0.1 |
|
| 2014 |
Bronson SL, Scott PD, Blessing JP, Riley JB. Response to letter "Going beyond manufacturers' limitations is not in the best interests of our patients" by Gerard J. Myers. The Journal of Extra-Corporeal Technology. 46: 103-4. PMID 24779129 |
0.09 |
|
| 2015 |
Troutman JM, Erickson KM, Scott PM, Hazel JM, Martinez CD, Dodbele S. Tuning the production of variable length, fluorescent polyisoprenoids using surfactant-controlled enzymatic synthesis. Biochemistry. 54: 2817-27. PMID 25897619 DOI: 10.1021/Acs.Biochem.5B00310 |
0.068 |
|
| 2019 |
Scott PM, Erickson KM, Troutman JM. Identification of the functional roles of six key proteins in the biosynthesis of Enterobacteriaceae colanic acid. Biochemistry. PMID 30821147 DOI: 10.1021/Acs.Biochem.9B00040 |
0.062 |
|
| 2007 |
Meurer WJ, Frederiksen SM, Majersik JJ, Zhang L, Sandretto A, Scott PA. Qualitative data collection and analysis methods: the INSTINCT trial. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 14: 1064-71. PMID 17652268 DOI: 10.1197/j.aem.2007.05.005 |
0.052 |
|
| 2009 |
Saver JL, Gornbein J, Grotta J, Liebeskind D, Lutsep H, Schwamm L, Scott P, Starkman S. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke. 40: 2433-7. PMID 19498197 DOI: 10.1161/Strokeaha.108.543561 |
0.051 |
|
| 2020 |
Yeow ZY, Lambrus BG, Marlow R, Zhan KH, Durin MA, Evans LT, Scott PM, Phan T, Park E, Ruiz LA, Moralli D, Knight EG, Badder LM, Novo D, Haider S, et al. Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. Nature. PMID 32908313 DOI: 10.1038/S41586-020-2690-1 |
0.05 |
|
| 1999 |
Tanne D, Bates VE, Verro P, Kasner SE, Binder JR, Patel SC, Mansbach HH, Daley S, Schultz LR, Karanjia PN, Scott P, Dayno JM, Vereczkey-Porter K, Benesch C, Book D, et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group. Neurology. 53: 424-7. PMID 10430444 DOI: 10.1212/WNL.53.2.424 |
0.049 |
|
| 2023 |
Scott P, Curinha A, Gliech C, Holland AJ. PLK4 self-phosphorylation drives the selection of a single site for procentriole assembly. The Journal of Cell Biology. 222. PMID 37773039 DOI: 10.1083/jcb.202301069 |
0.048 |
|
| 2009 |
Stulak JM, Dearani JA, Burkhart HM, Barnes RD, Scott PD, Schears GJ. ECMO cannulation controversies and complications. Seminars in Cardiothoracic and Vascular Anesthesia. 13: 176-82. PMID 19736214 DOI: 10.1177/1089253209347943 |
0.046 |
|
| 2020 |
Spector-Bagdady K, Higgins PDR, Aaronson KD, Birk J, Flaherty KR, Gregg KS, Hyzy RC, Kaul DR, Lauring AS, Magee JC, Meurer WJ, Park PK, Scott P, Lok AS. Coronavirus Disease 2019 (COVID-19) Clinical Trial Oversight at a Major Academic Medical Center: Approach of Michigan Medicine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 71: 2187-2190. PMID 32392334 DOI: 10.1093/cid/ciaa560 |
0.044 |
|
| 2007 |
Meurer W, Scott P, Caveney A, Silbergleit R. Poor Association between Hyperglycemia at Arrival and Clinical Outcomes in Acute Stroke Patients Treated with Tissue-type Plasminogen Activator Academic Emergency Medicine. 14: S30-S31. DOI: 10.1197/J.AEM.2007.03.774 |
0.044 |
|
| 2007 |
Meurer W, Scott P, Caveney A, Silbergleit R. Poor Association between Hyperglycemia at Arrival and Clinical Outcomes in Acute Stroke Patients Treated With Tissue-Type Plasminogen Activator The Journal of Emergency Medicine. 33: 331. DOI: 10.1016/J.JEMERMED.2007.08.030 |
0.044 |
|
| 2010 |
Meurer WJ, Caveney AF, Lo A, Zhang L, Frederiksen SM, Sandretto AM, Silbergleit R, Scott PA. Lack of association between pretreatment neurology consultation and subsequent protocol deviation in tissue plasminogen activator-treated patients with stroke. Stroke; a Journal of Cerebral Circulation. 41: 2098-101. PMID 20689081 DOI: 10.1161/STROKEAHA.110.588491 |
0.041 |
|
| 2010 |
Caveney AF, Silbergleit R, Frederiksen S, Meurer WJ, Hickenbottom SL, Smith RW, Scott PA. Resource utilization and outcome at a university versus a community teaching hospital in tPA treated stroke patients: a retrospective cohort study. Bmc Health Services Research. 10: 44. PMID 20170487 DOI: 10.1186/1472-6963-10-44 |
0.038 |
|
| 2024 |
Duan J, Keeler E, McFarland A, Scott P, Collman RG, Bushman FD. The virome of the kitome: small circular virus-like genomes in laboratory reagents. Microbiology Resource Announcements. e0126123. PMID 38591883 DOI: 10.1128/mra.01261-23 |
0.038 |
|
| 2018 |
Balucani C, Weingast SZ, Weedon J, Stefanov DG, Katz P, Hurley D, Khatri P, Broderick JP, Kasner SE, Grotta JC, Feldmann E, Panagos PD, Romano JG, Bianchi R, Meyer BC, ... Scott PA, et al. Abstract TMP77: To Treat or Not to Treat? A Survey Exploring Factors Influencing rt-PA Treatment Decisions for Minor Stroke Stroke. 49. DOI: 10.1161/STR.49.SUPPL_1.TMP77 |
0.038 |
|
| 2008 |
Scott PA, Ferchow L, Hobson A, Curzen NP. Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction. Emergency Medicine Journal : Emj. 25: 699-700. PMID 18843078 DOI: 10.1136/emj.2008.060574 |
0.037 |
|
| 2010 |
Meurer WJ, Scott PA, Caveney AF, Majersik JJ, Frederiksen SM, Sandretto A, Holden AB, Silbergleit R. Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator. International Journal of Stroke : Official Journal of the International Stroke Society. 5: 163-6. PMID 20536612 DOI: 10.1111/j.1747-4949.2010.00425.x |
0.036 |
|
| 2018 |
Levine SR, Weingast SZ, Weedon J, Stefanov DG, Katz P, Hurley D, Kasner SE, Khatri P, Broderick JP, Grotta JC, Feldmann E, Panagos PD, Romano JG, Bianchi R, Meyer BC, ... Scott PA, et al. To Treat or Not to Treat? Exploring Factors Influencing Intravenous Thrombolysis Treatment Decisions for Minor Stroke. Stroke. PMID 29976582 DOI: 10.1161/STROKEAHA.118.020971 |
0.036 |
|
| 2014 |
Sauser K, Burke JF, Levine DA, Scott PA, Meurer WJ. Time to brain imaging in acute stroke is improving: secondary analysis of the INSTINCT trial. Stroke; a Journal of Cerebral Circulation. 45: 287-9. PMID 24232449 DOI: 10.1161/STROKEAHA.113.003678 |
0.035 |
|
| 2004 |
Scott PA, Silbergleit R. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Annals of Emergency Medicine. 42: 611-8. PMID 14581912 DOI: 10.1016/S0196-0644(03)00443-8 |
0.033 |
|
| 2013 |
Meurer WJ, Kwok H, Skolarus LE, Adelman EE, Kade AM, Kalbfleisch J, Frederiksen SM, Scott PA. Does preexisting antiplatelet treatment influence postthrombolysis intracranial hemorrhage in community-treated ischemic stroke patients? An observational study. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 20: 146-54. PMID 23406073 DOI: 10.1111/Acem.12077 |
0.033 |
|
| 2013 |
Meurer WJ, Sozener CB, Xu Z, Frederiksen SM, Kade AM, Olgren M, Vieder SJ, Kalbfleish JD, Scott PA. The impact of emergency physician turnover on planning for prospective clinical trials. The Western Journal of Emergency Medicine. 14: 16-22. PMID 23447752 DOI: 10.5811/Westjem.2011.8.6798 |
0.033 |
|
| 2015 |
Adelman EE, Scott PA, Skolarus LE, Fox AK, Frederiksen SM, Meurer WJ. Protocol Deviations before and after Treatment with Intravenous Tissue Plasminogen Activator in Community Hospitals. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 26419527 DOI: 10.1016/j.jstrokecerebrovasdis.2015.08.036 |
0.033 |
|
| 2000 |
Tanne D, Gorman MJ, Bates VE, Kasner SE, Scott P, Verro P, Binder JR, Dayno JM, Schultz LR, Levine SR. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Stroke; a Journal of Cerebral Circulation. 31: 370-5. PMID 10657408 DOI: 10.1161/01.Str.31.2.370 |
0.033 |
|
| 2007 |
Samra SK, Giordani B, Caveney AF, Clarke WR, Scott PA, Anderson S, Thompson BG, Todd MM. Recovery of cognitive function after surgery for aneurysmal subarachnoid hemorrhage Stroke. 38: 1864-1872. PMID 17431208 DOI: 10.1161/Strokeaha.106.477448 |
0.032 |
|
| 2013 |
Pancioli AM, Adeoye O, Schmit PA, Khoury J, Levine SR, Tomsick TA, Sucharew H, Brooks CE, Crocco TJ, Gutmann L, Hemmen TM, Kasner SE, Kleindorfer D, Knight WA, Martini S, ... ... Scott PA, et al. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial. Stroke; a Journal of Cerebral Circulation. 44: 2381-7. PMID 23887841 DOI: 10.1161/Strokeaha.113.001059 |
0.031 |
|
| 2007 |
Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 115: e478-534. PMID 17515473 DOI: 10.1161/Circulationaha.107.181486 |
0.031 |
|
| 2007 |
Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke; a Journal of Cerebral Circulation. 38: 1655-711. PMID 17431204 DOI: 10.1161/Strokeaha.107.181486 |
0.031 |
|
| 2012 |
Skolarus LE, Scott PA, Burke JF, Adelman EE, Frederiksen SM, Kade AM, Kalbfleisch JD, Ford AL, Meurer WJ. Antihypertensive treatment prolongs tissue plasminogen activator door-to-treatment time: secondary analysis of the INSTINCT trial. Stroke; a Journal of Cerebral Circulation. 43: 3392-4. PMID 23033348 DOI: 10.1161/Strokeaha.112.662684 |
0.031 |
|
| 2007 |
Silbergleit R, Scott P, Wang X. Performance Characteristics of Endovascular Cooling Devices for Inducing Hypothermia after Cardiac Arrest The Journal of Emergency Medicine. 33: 324. DOI: 10.1016/J.JEMERMED.2007.08.014 |
0.03 |
|
| 2020 |
Smith BB, Nuttall GA, Mauermann WJ, Schroeder DR, Scott PD, Smith MM. Coagulation test changes associated with acute normovolemic hemodilution in cardiac surgery. Journal of Cardiac Surgery. PMID 32248625 DOI: 10.1111/jocs.14532 |
0.03 |
|
| 2015 |
Skolarus LE, Meurer WJ, Shanmugasundaram K, Adelman EE, Scott PA, Burke JF. Marked Regional Variation in Acute Stroke Treatment Among Medicare Beneficiaries. Stroke; a Journal of Cerebral Circulation. 46: 1890-6. PMID 26038520 DOI: 10.1161/STROKEAHA.115.009163 |
0.029 |
|
| 2010 |
Scott PA, Xu Z, Meurer WJ, Frederiksen SM, Haan MN, Westfall MW, Kothari SU, Morgenstern LB, Kalbfleisch JD. Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke; a Journal of Cerebral Circulation. 41: 2026-32. PMID 20705931 DOI: 10.1161/Strokeaha.110.581942 |
0.029 |
|
| 1998 |
Scott PA, Temovsky CJ, Lawrence K, Gudaitis E, Lowell MJ. Analysis of Canadian Population With Potential Geographic Access to Intravenous Thrombolysis for Acute Ischemic Stroke Stroke. 29: 2304-2310. PMID 9804638 DOI: 10.1161/01.Str.29.11.2304 |
0.029 |
|
| 2006 |
Scott PA, Silbergleit R. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke. 37: 943-4; author reply . PMID 16567664 DOI: 10.1161/01.STR.0000210181.05204.EB |
0.026 |
|
| 2014 |
Weston VC, Meurer WJ, Frederiksen SM, Fox AK, Scott PA. Prevention of emergency physician migratory contamination in a cluster randomized trial to increase tissue plasminogen activator use in stroke (the INSTINCT trial). The American Journal of Emergency Medicine. 32: 1460-3. PMID 25440230 DOI: 10.1016/j.ajem.2014.08.073 |
0.026 |
|
| 2002 |
Scott PA, Pancioli AM, Davis LA, Frederiksen SM, Eckman J. Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke; a Journal of Cerebral Circulation. 33: 2664-9. PMID 12411658 DOI: 10.1161/01.STR.0000035260.70403.88 |
0.026 |
|
| 2005 |
Scott P. Management of acute ischemic stroke. Seminars in Respiratory and Critical Care Medicine. 23: 69-81. PMID 16088599 DOI: 10.1055/S-2002-20590 |
0.026 |
|
| 2003 |
Scott PA. Long Term Mortality in Stroke Patients Treated with TPA: Emergency Physicians vs NINDS Physicians Academic Emergency Medicine. 10: 433-433. DOI: 10.1197/AEMJ.10.5.433 |
0.025 |
|
| 1998 |
Scott PA, Wolf LR, Spadafora MP. Accuracy of reagent strips in detecting hypoglycemia in the emergency department. Annals of Emergency Medicine. 32: 305-9. PMID 9737491 DOI: 10.1016/S0196-0644(98)70005-8 |
0.025 |
|
| 2004 |
Silbergleit R, Scott PA, Lowell MJ, Silbergleit R. Cost-effectiveness of helicopter transport of stroke patients for thrombolysis. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 10: 966-72. PMID 12957981 DOI: 10.1197/S1069-6563(03)00316-6 |
0.025 |
|
| 2008 |
Connell E, Scott P, Davletov B. Real-time assay for monitoring membrane association of lipid-binding domains. Analytical Biochemistry. 377: 83-8. PMID 18342614 DOI: 10.1016/J.Ab.2008.02.016 |
0.025 |
|
| 2013 |
Scott PA, Meurer WJ, Frederiksen SM, Kalbfleisch JD, Xu Z, Haan MN, Silbergleit R, Morgenstern LB. A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial. The Lancet. Neurology. 12: 139-48. PMID 23260188 DOI: 10.1016/S1474-4422(12)70311-3 |
0.025 |
|
| 1999 |
Smith RW, Scott PA, Grant RJ, Chudnofsky CR, Frederiksen SM. Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 6: 618-25. PMID 10386679 DOI: 10.1111/J.1553-2712.1999.TB00416.X |
0.025 |
|
| 2019 |
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. STR0000000000000211. PMID 31662037 DOI: 10.1161/Str.0000000000000211 |
0.025 |
|
| 2008 |
Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J, Kasner S, Kidwell C, ... ... Scott P, et al. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke; a Journal of Cerebral Circulation. 39: 3268-76. PMID 18772447 DOI: 10.1161/Strokeaha.108.517656 |
0.025 |
|
| 2014 |
West DJ, Cunningham DJ, Finn CV, Scott PM, Crewther BT, Cook CJ, Kilduff LP. The metabolic, hormonal, biochemical, and neuromuscular function responses to a backward sled drag training session Journal of Strength and Conditioning Research. 28: 265-272. PMID 23575361 DOI: 10.1519/JSC.0b013e3182948110 |
0.024 |
|
| 2004 |
Suzuki S, Saver JL, Scott P, Jahan R, Duckwiler G, Starkman S, Su Y, Kidwell CS. Access to intra-arterial therapies for acute ischemic stroke: An analysis of the US population American Journal of Neuroradiology. 25: 1802-1806. PMID 15569751 |
0.024 |
|
| 1991 |
Scott PA, Gibler WB, Dronen SC. Acute myocardial infarction presenting as flank pain and tenderness: report of a case. The American Journal of Emergency Medicine. 9: 547-50. PMID 1930394 DOI: 10.1016/0735-6757(91)90109-W |
0.023 |
|
| 2013 |
Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke; a Journal of Cerebral Circulation. 44: 870-947. PMID 23370205 DOI: 10.1161/Str.0B013E318284056A |
0.023 |
|
| 2013 |
Levine SR, Khatri P, Broderick JP, Grotta JC, Kasner SE, Kim D, Meyer BC, Panagos P, Romano J, Scott P. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke; a Journal of Cerebral Circulation. 44: 2500-5. PMID 23847249 DOI: 10.1161/STROKEAHA.113.000878 |
0.023 |
|
| 2002 |
Scott PA. Emergency Physician Administration of rt-PA in Acute Stroke: Five-year Analysis of Treatment and Outcome Academic Emergency Medicine. 9: 447-a-447. DOI: 10.1197/AEMJ.9.5.447-A |
0.022 |
|
| 2009 |
Riley JB, Scott PD, Schears GJ. Update on safety equipment for extracorporeal life support (ECLS) circuits. Seminars in Cardiothoracic and Vascular Anesthesia. 13: 138-45. PMID 19720681 DOI: 10.1177/1089253209347895 |
0.021 |
|
| 2023 |
Scott P, Curinha A, Gliech C, Holland AJ. Correction: PLK4 self-phosphorylation drives the selection of a single site for procentriole assembly. The Journal of Cell Biology. 223. PMID 38095873 DOI: 10.1083/jcb.20230106912112023c |
0.02 |
|
| 2021 |
Miller DD, Bajracharya A, Dickinson GN, Durbin TA, McGarry JKP, Moser EP, Nuñez LA, Pukkila EJ, Scott PS, Sutton PJ, Johnston NAC. Diffusive uptake rates for passive air sampling: Application to volatile organic compound exposure during FIREX-AQ campaign. Chemosphere. 287: 131808. PMID 34461330 DOI: 10.1016/j.chemosphere.2021.131808 |
0.02 |
|
| 2009 |
Scott PA. Enhancing community delivery of tissue plasminogen activator in stroke through community-academic collaborative clinical knowledge translation. Emergency Medicine Clinics of North America. 27: 115-36, ix. PMID 19218023 DOI: 10.1016/j.emc.2008.07.001 |
0.02 |
|
| 2012 |
Majersik JJ, Meurer WJ, Frederiksen SA, Sandretto AM, Xu Z, Goldman EB, Scott PA. Observational study of telephone consults by stroke experts supporting community tissue plasminogen activator delivery. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 19: E1027-34. PMID 22978729 DOI: 10.1111/J.1553-2712.2012.01438.X |
0.02 |
|
| 2008 |
Flick RP, Sprung J, Gleich SJ, Barnes RD, Warner DO, Dearani JA, Scott PD, Hanson AC, Schroeder DR, Schears GJ. Intraoperative extracorporeal membrane oxygenation and survival of pediatric patients undergoing repair of congenital heart disease. Paediatric Anaesthesia. 18: 757-66. PMID 18544147 DOI: 10.1111/j.1460-9592.2008.02632.x |
0.02 |
|
| 2011 |
Meurer WJ, Majersik JJ, Frederiksen SM, Kade AM, Sandretto AM, Scott PA. Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study. Bmc Emergency Medicine. 11: 5. PMID 21548943 DOI: 10.1186/1471-227X-11-5 |
0.019 |
|
| 2022 |
Dickinson GN, Miller DD, Bajracharya A, Bruchard W, Durbin TA, McGarry JKP, Moser EP, Nuñez LA, Pukkila EJ, Scott PS, Sutton PJ, Johnston NAC. Health Risk Implications of Volatile Organic Compounds in Wildfire Smoke During the 2019 FIREX-AQ Campaign and Beyond. Geohealth. 6: e2021GH000546. PMID 36017488 DOI: 10.1029/2021GH000546 |
0.019 |
|
| 2011 |
Kocher KE, Meurer WJ, Fazel R, Scott PA, Krumholz HM, Nallamothu BK. National trends in use of computed tomography in the emergency department. Annals of Emergency Medicine. 58: 452-62.e3. PMID 21835499 DOI: 10.1016/J.Annemergmed.2011.05.020 |
0.018 |
|
| 2020 |
Scott PS, Andrew JP, Bundy BA, Grimm BK, Hamann MA, Ketcherside DT, Li J, Manangquil MY, Nuñez LA, Pittman DL, Rivero-Zevallos A, Uhlorn R, Johnston NAC. Observations of volatile organic and sulfur compounds in ambient air and health risk assessment near a paper mill in rural Idaho, U. S. A. Atmospheric Pollution Research. 11: 1870-1881. PMID 33162775 DOI: 10.1016/j.apr.2020.07.014 |
0.018 |
|
| 1998 |
Alberts MJ, Chaturvedi S, Graham G, Hughes RL, Jamieson DG, Krakowski F, Raps E, Scott P. Acute stroke teams results of a national survey Stroke. 29: 2318-2320. PMID 9804640 DOI: 10.1161/01.STR.29.11.2318 |
0.018 |
|
| 1999 |
Scott P, Davis L, Beck P. Residency training on the use of thrombolytic therapy for acute stroke Journal of Stroke and Cerebrovascular Diseases. 8: 276. DOI: 10.1016/S1052-3057(99)80099-8 |
0.018 |
|
| 2018 |
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. PMID 29367334 DOI: 10.1016/J.Jvs.2018.04.007 |
0.017 |
|
| 2015 |
Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, Scott PA, Selim MH, Woo D. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke; a Journal of Cerebral Circulation. 46: 2032-60. PMID 26022637 DOI: 10.1161/STR.0000000000000069 |
0.016 |
|
| 2013 |
Sauser K, Burke J, Scott P, Levine D, Meurer M. Improving Time to Brain Imaging in Acute Stroke: Analysis of the Increasing Stroke Treatment through Interventional Behavioral Change Tactics (INSTINCT) Trial Annals of Emergency Medicine. 62: S129. DOI: 10.1016/J.ANNEMERGMED.2013.07.188 |
0.016 |
|
| 2010 |
Scott PA, Frederiksen SM, Kalbfleisch JD, Xu Z, Meurer WJ, Caveney AF, Sandretto A, Holden AB, Haan MN, Hoeffner EG, Ansari SA, Lambert DP, Jaggi M, Barsan WG, Silbergleit R. Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 17: 1062-71. PMID 21040107 DOI: 10.1111/J.1553-2712.2010.00868.X |
0.015 |
|
| 2007 |
Mecozzi AC, Brown DL, Lisabeth LD, Barsan WG, Silbergleit R, Hickenbottom SL, Scott PA, Morgenstern LB. Determining intravenous rt-PA eligibility in the Emergency Department. Neurocritical Care. 7: 103-8. PMID 17763833 DOI: 10.1007/S12028-007-0065-1 |
0.014 |
|
| 2014 |
Skolarus LE, Morgenstern LB, Scott PA, Lisabeth LD, Murphy JB, Migda EM, Brown DL. An emergency department intervention to increase warfarin use for atrial fibrillation. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 23: 199-203. PMID 23265781 DOI: 10.1016/J.Jstrokecerebrovasdis.2012.11.005 |
0.013 |
|
| 2015 |
Scott P, Robinson K, Mongkolrattanothai K, Camp T. Medical evaluation of abandoned infants less than 61 days of age. Hospital Pediatrics. 5: 282-6. PMID 25934813 DOI: 10.1542/hpeds.2014-0113 |
0.012 |
|
| 2005 |
Silbergleit R, Scott PA. Thrombolysis for acute stroke: the incontrovertible, the controvertible, and the uncertain. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 12: 348-51. PMID 15805327 DOI: 10.1197/J.AEM.2004.10.027 |
0.011 |
|
| 2019 |
Beam WB, Scott PD, Wijdicks EFM. The Physiology of the Apnea Test for Brain Death Determination in ECMO: Arguments for Blending Carbon Dioxide. Neurocritical Care. PMID 31396840 DOI: 10.1007/S12028-019-00784-7 |
0.01 |
|
| 2006 |
Scott PA. For rich and poor, the message is still "dial 9-1-1": but is it getting through? Stroke. 37: 1354-5. PMID 16690894 DOI: 10.1161/01.STR.0000226045.48106.1A |
0.01 |
|
| 2001 |
Scott PA, Davis LA. Do not substitute: IV thrombolytic selection errors in acute stroke [1] Stroke. 32: 580. PMID 11157205 DOI: 10.1161/01.STR.32.2.580 |
0.01 |
|
| Hide low-probability matches. |